Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 29, 2024 -- Clinicians fail to rescue female patients with complications after high-risk vascular and cardiac surgeries more often than male patients, according to a study published online Oct. 16 in JAMA Surgery.
Catherine M. Wagner, M.D., from Michigan Medicine in Ann Arbor, and colleagues examined whether female patients die more often than male patients after high-risk surgery because female patients have more complications or because clinicians fail to rescue them from those complications. The analysis included data from 863,305 Medicare beneficiaries undergoing high-risk vascular or cardiac surgery (October 2015 to February 2020).
The researchers found that female and male patients had similar rates of complications (female, 14.98 percent; male, 14.37 percent; adjusted relative risk, 1.04). Female patients had higher rates of 30-day mortality (female, 4.22 percent; male, 3.34 percent; adjusted relative risk, 1.26) and higher rates of failure to rescue (female, 10.71 percent; male, 8.58 percent; adjusted relative risk, 1.25). When examining outcomes by procedure, findings persisted.
"Female patients undergoing high-risk surgery are more likely to die of postoperative complications than male patients, and efforts to recognize and respond to complications before they result in death may narrow the sex disparity in mortality after high-risk surgery," the authors write.
One author disclosed ties to the medical device industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-30 06:00
Read more
- Weed Use During Pregnancy May Harm Kids' Behavior, Thinking Skills
- Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome
- TCI Unveils Promising GLP-1 Formula Clinical Trial Results for Advanced Weight Management
- Think Your Opinion Must Be Right? Science Reveals Why You May Be Wrong
- Severe COVID Case Ups Heart Risks As Much as History of Heart Disease
- Gilead Signs Royalty-Free Voluntary Licensing Agreements with Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions